Cardurion Pharma Stock

cardurion.comHealthcare / Healthcare softwareFounded: 2017Funding to Date: $366.93MM

This company has pioneered the inhibition of CaMKII, a key player in cardiac function, marking a significant advancement in cardiovascular disease treatment by being the first to take a CaMKII inhibitor into a Phase 1 clinical trial in Q3 2022. This innovation opens avenues for rapid development in treating rare arrhythmias and broader cardiovascular diseases, including heart failure. Additionally, the company is exploring PDE9 inhibition as a foundational treatment for chronic heart failure, aiming to surpass existing treatments like Entresto with a next-generation neurohumoral drug. Through acquiring, discovering, and innovating, the company is at the forefront of transforming cardiovascular disease management.

Register To Buy and Sell Shares

For more details on financing and valuation for Cardurion Pharma, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access Cardurion Pharma’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Cardurion Pharma.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.

Frequently Asked Questions About Cardurion Pharma’s Stock

Can you buy Cardurion Pharma’s stock?
Cardurion Pharma is not publicly traded on NYSE or NASDAQ in the U.S. To buy Cardurion Pharma’s stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
Can you sell Cardurion Pharma’s stock?
Yes, you can sell stock of a private company like Cardurion Pharma. Forge can help you sell your Cardurion Pharma stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
What is Cardurion Pharma’s stock price?
Cardurion Pharma is a privately held company and therefore does not have a public stock price. However, you may access Cardurion Pharma’s private market stock price with Forge Data.
What is Cardurion Pharma’s stock ticker symbol?
Cardurion Pharma does not have an official ticker symbol because this company is not currently publicly traded.
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.
Updated on: May 23, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.